Edirne

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Active, not recruiting

  A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

  NCT02246621· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

  NCT02152631· Phase 3· Eli Lilly and Company· Source